Skip to content

Clinical trials

Completed Polycythemia Vera trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Status: Completed Clear all

147 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20013
20028
20031
20045
200511
20068
200710
20086
20095
20107
20116
20128
20137
20149
20157
20161
20174
20182
20194
20202
20214
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed147

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Fred Hutchinson Cancer Center10
M.D. Anderson Cancer Center9
Novartis Pharmaceuticals6
Incyte Corporation5
AOP Orphan Pharmaceuticals AG4
Icahn School of Medicine at Mount Sinai4
Case Comprehensive Cancer Center3
European Organisation for Research and Treatment of Cancer - EORTC3
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera147
Primary Myelofibrosis104
Thrombocythemia, Essential103
Myeloproliferative Disorders89
Leukemia, Myeloid, Acute57
Leukemia, Myelomonocytic, Chronic57
Precursor Cell Lymphoblastic Leukemia-Lymphoma57
Leukemia, Lymphocytic, Chronic, B-Cell55
Multiple Myeloma49
Burkitt Lymphoma46

Trials

Showing 26 to 50 of 147. Each trial links to its page on Pharma Observatory.

47 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.